Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support.
NCT ID: NCT06396156
Last Updated: 2024-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2022-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes of the Corneal Endothelial Cell Count After Artisan Phakic Intraocular Lens Implantation
NCT03266354
Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in Adults
NCT01547429
Manually Performed Limbal Relaxing Incisions vs Femtosecond Laser-guided Astigmatic Keratotomy
NCT03264534
Toric Intraocular Lens Implantation for Pediatric Aphakia
NCT07088796
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
NCT01763151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients recruited for this study will be assigned into 2 groups:
1. Group A: will have implantation of an anterior chamber iris-claw lens (Ophtec BV, Groningen, The Netherlands)
2. Group B: Wil have implantation of a retropupillary iris-claw lens (Ophtec BV, Groningen, The Netherlands)
Preoperative Evaluation
Demographics and History Taking Baseline demographic data will be collected from all patients including
1. Age at time of surgery
2. Gender
3. Laterality
4. History of trauma
5. History of any previous ocular interventions.
Systemic Workup:
Patients without evidence of trauma had a complete workup in conjunction with a pediatrician for the underlying cause of subluxation or absent capsular support
Ocular Examination:
* Measurement of best-corrected visual (BCVA) using the tumbling E chart or the Allen's picture chart will be done. Visual acuity will be expressed as logMAR acuity
* Detailed slit lamp examination:
Evaluation of the cornea for clarity and regularity Evaluation of the anterior chamber Evaluation of the iris for - Iris structure and iris defects - Tremulousness
\- Sphincteric ruptures and traumatic injuries to the iris including iridodialysis, atrophy, and traumatic aniridia
\- Synechiae between the iris and the lens/capsular remnants Examination of the pupil for
\- Pupil size undilated and after dilatation
\- Centralization of the pupil Evaluation of the capsular support and any residual lens matter, Sommering ring, or Elschninng pearls in aphakic cases Evaluation of the lens in subluxated cases for
\- Extent of subluxation
\- Direction of subluxation
\- Integrity of the zonules including any elongation or anomalies in the zonules
\- Relation of the lens to the center of the pupil through an undilated and a dilated exam
\- Clarity of the lens
\- Change in the lens position with the supine position
\- Tremulousness' of the lens
\- Dilated fundus examination using both slit lamp biomicroscopy and indirect ophthalmoscopy.
\- Measurement of the IOP using Perkins tonometer (Haag Streit, UK): Measurement of IOP will be done under topical anesthesia in cooperative children and under general anesthesia at the start of surgery in uncooperative children
* Examination of the angle of anterior chamber using the Swan- Jacob's goniolens under general anesthesia at the start of the surgery.
* Evaluation of central corneal thickness (CCT) using a handheld pachymeter (DGH55, Exton, USA).
Evaluation of corneal endothelium:
Corneal endothelial cell count (ECC) will be evaluated using non-contact Specular Microscope (Konan Medical KSS-300, Inc., Hyogo, Japan) for all children. only sharp images with easily identified cell borders will be analyzed. The endothelial cell density (ECD) will be calculated with center method in all images. Fixed number of cells will be used in all scans to eliminate variability. Manual selection of cells will be performed in all scans. A single island of contiguous cells with well identified borders will be used for calculations.
Anterior Segment Optical Coherence Tomography (AS-OCT):
All subject eyes will be scanned with a hand-held anterior segment optical coherence tomography (HH AS-OCT); RTVue RT-100 system (Optovue Inc., Fremont, CA). A non-contact technique will be used for scanning, with the child lying supine without sedation. All scans will be performed with the pupil undilated and under mesopic conditions. each eye will be imaged at least 3 scans per visit.
Corneal thickness mapping:
A pachymetry scan pattern, with 6-mm scan diameter and eight radials, will be chosen to map the cornea. The RTVue corneal adapter module software provided the pachymetry map of total corneal thickness, automatically. Central corneal thickness will be automatically calculated in µm as the central distance between the epithelium and endothelium.
Anterior chamber angle assessment:
* Image acquisition:
Scanning of the angle will be performed on the nasal and temporal quadrants at 3 and 9 o'clock under mesopic conditions with the device's software set to Angle mode. In this mode, a 3 x 2.3 mm area centered at the limbus will be analyzed. Each quadrant will be scanned three times, and the investigator will choose the image showing the best quality and least noise.
\- Angle morphology: Identification of the anterior chamber angle structures will be performed. Identification of scleral spur (SS) (The anatomical landmark), trabecular meshwork, Schlemm's canal before surgery.
Angle abnormalities including abnormal angle membrane, peripheral anterior synechiae (PAS), primary congenital glaucoma (PCG) like changes will be documented in pre and postoperative scans.
\- Anterior chamber angle parameters The anterior chamber (AC) angle width The angle opening distance (AOD) (µm)
IOL power calculation:
IOL power calculation will be performed using optical biometry. In uncooperative children and children in whom optical biometry could not be performed, an A-scan biometry will be performed using contact technique. IOL power will be calculated using either SRK-T and Holladay 1 formula. An A constant of 115.7 and 116.8 will be assigned for the anterior chamber and posterior iris-claw lens, respectively. Emmetropia will be targeted in all patients.
Surgical technique:
All surgeries will be performed under general anesthesia. In all the eyes that required lensectomy, the procedure will be performed through an anterior corneal approach. A 23-gauge MVR knife will be used to create two side ports at 3 o'clock and 9 o'clock. A cohesive viscoelastic will be injected in retrolenticular space. Then, the MVR blade will be used to create 2 incisions at the equator of the subluxated lens, and slightly widened. A 23-gauge bimanual irrigation and aspiration system will be used to aspirate lens matter. Then a 23-G vitrectomy probe will be used for lens capsule removal. Sweeping of anterior chamber using spatula will be performed to ensure the absence of vitreous strands. Miosis will be achieved by injecting intra-cameral pilocarpine 1% then a peripheral iridectomy at 11 or 1 o'clock will be performed using the vitrector probe. A cohesive viscoelastic will be injected, and then a superior limbal corneal incision of 6 mm will be constructed, but not opened. In Group A, anterior chamber iris claw fixation will be done. The lens will be introduced using the curved Clayman forceps with its vault facing up, and then enclavated at 3 and 9 o'clock positions anterior to the iris. In the retropupillary group (Group B), the IOL will be introduced behind the pupil and enclavated behind the iris. Corneal wounds will be them closed using 10/0 nylon sutures.
Postoperative regimen:
Topical steroids and antibiotics will be prescribed for 6-8 weeks after surgery. Topical tropicamide 1% will be prescribed to be used twice per day for 1 week to decrease pigment dispersion. Removal of sutures will be done 6 weeks after surgery.
Postoperative Follow-Up:
Patients will be followed up at 1 day, 1 week, 1 month, 6 months, and 12 months after surgery. More frequent follow-up will be performed whenever needed.
<!-- -->
1. Clinical examination:
All patients will be examined on the first day after surgery for o Corneal clarity o Anterior chamber reaction and pigment dispersion o Stability and centration of the IOL o Patency of the peripheral iridectomy
o IOP measurement Clinical examination will be then repeated at each follow-up visit
2. Automated refraction or retinoscopy and prescription of spectacles:
A dilated refraction will be performed 2 weeks after suture removal (8 weeks after surgery), Any residual refractive error will be corrected fully in all patients using single vision glasses. In older children, bifocal spectacles will be prescribed.
3. Measurement of best-corrected visual acuity (BCVA) Measurement of BCVA will be performed after prescription of spectacles, then repeated at 6 and 12 months. Tumbling E chart will be used for literate children. Teller cards will be used in few illiterate children. Children who show interocular difference in the visual acuity ≥ 3 logMAR lines will be prescribed patching to the better seeing eye according to the PEDIG guidelines.
4. Measurement of central endothelial cell density A repeat specular microscopy will be performed at 1 month, 6 months, and 12 months after surgery. Sharp images with easily identified cell borders will be analyzed. Manual center method will be used for cell identification. Fixed number of cells will be used in all analyses.
5. Assessment of changes in central corneal thickness and anterior chamber angle will be performed using hand-held optical coherence tomography (OCT), A repeat anterior segment OCT will be performed at 1 month, 6 months, and 12 months after surgery.
6. Ultrasound biomicroscopy:
UBM scanning (VuMAX HD, Sonomed Escalon, New York) will be performed at the end of 1-year follow-up. Examination will be performed with the patient in the supine position to measure IOL tilt and decentration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
anterior chamber iris-claw lens
Eyes that receive Artisan IOL that is fixed anterior to the iris
Anterior enclavation
Anterior enclavation of iris-claw lens
Retro-pupillary Iris- Claw lens
Eyes that receive Artisan IOL that is fixed posterior to the iris
Posterior enclavation
Posterior enclavation of iris-claw lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anterior enclavation
Anterior enclavation of iris-claw lens
Posterior enclavation
Posterior enclavation of iris-claw lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Traumatic lens subluxation that requires lensectomy and intraocular lens implantation.
* Microspherophakia that requires lensectomy and intraocular lens implantati
* Aphakia with insufficient capsular support.
Exclusion Criteria
* Preoperative anterior chamber depth (ACD) less than 3 mm.
* Severely damaged iris.
* History of uveitis or glaucoma.
* Macular lesions or previous retinal surgery
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Awadein
Professor of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hatem Saeed, MD
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University Pediatric Hospital
Cairo, , Egypt
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gawdat GI, Taher SG, Salama MM, Ali AA. Evaluation of Artisan aphakic intraocular lens in cases of pediatric aphakia with insufficient capsular support. J AAPOS. 2015 Jun;19(3):242-6. doi: 10.1016/j.jaapos.2015.03.014.
Yulia DE, Barliana JD, Soeharto DA. Visual outcome of intraocular Iris-Claw lens implantation in Indonesian children with ectopia lentis. Taiwan J Ophthalmol. 2022 Feb 28;13(3):335-340. doi: 10.4103/tjo.tjo_58_21. eCollection 2023 Jul-Sep.
Cevik SG, Cevik MO, Ozmen AT. Iris-claw intraocular lens implantation in children with ectopia lentis. Arq Bras Oftalmol. 2017 Mar-Apr;80(2):114-117. doi: 10.5935/0004-2749.20170027.
Yulia DE, Soeharto DA. Efficacy and Safety of Iris-Claw Intraocular Lens in Pediatric Ectopia Lentis: A Literature Review. J Curr Ophthalmol. 2023 Aug 11;35(1):1-10. doi: 10.4103/joco.joco_249_22. eCollection 2023 Jan-Mar.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD-45-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.